Investors Land MNTA Even Cheaper Than Its Secondary Stock Offering
December 11, 2018 at 15:25 PM EST
Looking back to 5 days ago, Momenta Pharmaceuticals Inc (MNTA) priced a 17,391,305 share secondary stock offering at $11.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..